Fresenius Dialysis Treatment Injuries
Patients who were injured after receiving hemodialysis treatment with GranuFlo and NaturaLyte products have begun filing lawsuits against the manufacturer, Fresenius Medical Care (FMC). Fresenius Medical Care owns thousands of dialysis clinics across the United States and manufactures most of the dialysis products used in their centers.
GranuFlo acid concentrate powder and NaturaLyte liquid acid concentrate contain sodium diacetate, which can result in bicarbonate overdoses for dialysis patients that already have elevated bicarbonate levels before beginning treatment. High bicarbonate blood levels can lead to severe side effects such as heart attack, stroke, myocardial infarction and sudden death.
Fresenius Medical Care released an internal memo in November 2011 reporting that patients undergoing dialysis treatments with GranuFlo and NaturaLyte products are at a six times greater risk of suffering a stroke or heart attack than patients using other dialysis products. Fresenius also stated that 941 patients had suffered sudden cardiac arrest in Fresenius dialysis facilities in 2010.
In March 2012, the Food and Drug Administration (FDA) issued a Class 1 recall of all GranuFlo and NaturaLyte products after receiving a leaked copy of the Fresenius Medical Care internal memo.
If you or a loved one has been injured after receiving dialysis treatment with GranuFlo or NaturaLyte, you may be eligible to file a lawsuit. Contact the lawyers at Hissey Kientz, LLP for a free case evaluation by calling toll-free at 1-866-275-4454, or by filling out our free contact form on the right of this page.